Laurus Labs Limited Laurus Labs Limited

Laurus Labs Limited

LAURUSLABS

株式のランク #1745
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
株価
$22.83
最終同期: 2026-10-19
時価総額
$12.34B
変化(1日)
0.51%
変化(1年)
117.95%
国
IN
取引 Laurus Labs Limited (LAURUSLABS)

カテゴリー

Healthcare
Laurus Labs Limited(LAURUSLABS)の株式分割履歴
Laurus Labs Limited株(シンボル:LAURUSLABS)は合計で1回の株式分割を実施しました。
最新の株式分割はSep 29, 2020に行われました。
Sep 29, 2020より前に購入されたLAURUSLABS株は、現在5LAURUSLABS株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2020-09-29 5:1 x5 x5
類似企業または競合他社の株式分割